Skip to main content

Advertisement

SpringerLink
Log in

Metastatic lymph node ratio (LNR) as a prognostic variable in colorectal cancer patients undergoing laparoscopic resection

  • Original Article
  • Published:
Techniques in Coloproctology Aims and scope Submit manuscript

Abstract

Background

Lymph node ratio (LNR: the ratio of metastatic to total retrieved nodes) has shown prognostic significance in several tumors. Its role in patients with colorectal cancer submitted to laparoscopic resection is still not clearly defined. The aim of this study was to evaluate the impact of LNR on long-term outcome in patients undergoing curative laparoscopic resection.

Methods

Patients’ data were retrieved from our prospective in-hospital collected data of patients that underwent laparoscopic surgery for curable colorectal cancer over a 6-year period. Long-term data were collected from our outpatient’s clinic data and personal contact when necessary.

Results

Two hundred and five patients underwent laparoscopic resection for curable colorectal cancer in the study period. Sixty-five patients were node positive. Receiver operating characteristic (ROC) analysis selected 0.13 as the best LNR cutoff value in this group. Kaplan–Meier 5-year survival analysis revealed a significant decrease in overall and disease-free survival in patients with an LNR above 0.13. Long-term outcome of patients with an LNR below 0.13 was similar to node-negative stage II patients.

Conclusions

The lymph node ratio is a valuable prognostic factor in node-positive colon cancer patients undergoing laparoscopic resection. Patients with an LNR below 0.13 have the same long-term outcome as stage II node-negative patients. The laparoscopic approach presents the same trends in terms of overall survival and disease-free survival as conventional open access when LNR is considered.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer statistics, 2009 CA. Cancer J Clin 59:225–249

    Article  Google Scholar 

  2. Samantas E, Dervenis C, Rigatos SK (2007) Adjuvant chemotherapy for colon cancer: evidence on improvement in survival. Dig Dis 25:67–75

    Article  PubMed  CAS  Google Scholar 

  3. Ratto C, Sofo L, Ippoliti M et al (1999) Accurate lymph-node detection in colorectal specimens resected for cancer is of prognostic significance. Dis Colon Rectum 42:143–154

    Article  PubMed  CAS  Google Scholar 

  4. Baxter NN, Virnig DJ, Rothenberger DA, Morris AM, Jessurun J, Virnig BA (2005) Lymph node evaluation in colorectal cancer patients: a population-based study. J Natl Cancer Inst 97:219–225

    Article  PubMed  Google Scholar 

  5. Ostadi MA, Harnish JL, Stegienko S, Urbach DR (2007) Factors affecting the number of lymph nodes retrieved in colorectal cancer specimens. Surg Endosc 21:2142–2146

    Article  PubMed  Google Scholar 

  6. Berger AC, Sigurdson ER, LeVoyer T et al (2005) Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes. J Clin Oncol 23:8706–8712

    Article  PubMed  Google Scholar 

  7. Lee HY, Choi HJ, Park KJ et al (2007) Prognostic significance of metastatic lymph node ratio in node- positive colon carcinoma. Ann Surg Oncol 14:1712–1717

    Article  PubMed  Google Scholar 

  8. El-Gazzaz G, Hull T, Hammel J, Geisler D (2010) Does a laparoscopic approach affect the number of lymph nodes harvested during curative surgery for colorectal cancer? Surg Endosc 24:113–118

    Article  PubMed  Google Scholar 

  9. Moertel CG (1994) Chemotherapy for colorectal cancer. N Engl J Med 330:1136–1142

    Article  PubMed  CAS  Google Scholar 

  10. Tang R, Wang JY, Chen JS et al (1995) Survival impact of lymph node metastasis in TNM stage III carcinoma of the colon and rectum. J Coll Surg 180:705–712

    CAS  Google Scholar 

  11. Chang GJ, Rodriguez-Bigas MA, Skibber JM, Moyer VA (2007) Lymph node evaluation and survival after curative resection of colon cancer: systematic review. J Natl Cancer Inst 99:433–441

    Article  PubMed  Google Scholar 

  12. Swanson RS, Compton CC, Stewart AK, Bland KI (2003) The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined. Ann Surg Oncol 10:65–71

    Article  PubMed  Google Scholar 

  13. Rosenberg R, Friederichs J, Schuster T et al (2008) Prognosis of patients with colorectal cancer is associated with lymph node ratio: a single-center analysis of 3, 026 patients over a 25-year time period. Ann Surg 248:968–978

    Article  PubMed  Google Scholar 

  14. Chin CC, Wang JY, Yeh CY, Kuo YH, Huang WS, Yeh CH (2009) Metastatic lymph node ratio is a more precise predictor of prognosis than number of lymph node metastases in stage III colon cancer. Int J Colorectal Dis 24:1297–1302

    Article  PubMed  Google Scholar 

  15. Galizia G, Orditura M, Ferraraccio F et al (2009) The lymph node ratio is a powerful prognostic factor of node-positive colon cancers undergoing potentially curative surgery. World J Surg 33:2704–2713

    Article  PubMed  Google Scholar 

  16. Wang J, Hassett JM, Dayton MT, Kulaylat MN (2008) Lymph node ratio: role in the staging of node-positive colon cancer. Ann Surg Oncol 15:1600–1608

    Article  PubMed  Google Scholar 

  17. Inoue K, Nakane Y, Iiyama H et al (2002) The superiority of ratio-based lymph node staging in gastric carcinoma. Ann Surg Oncol 9:27–34

    Article  PubMed  Google Scholar 

  18. Megale Costa LJ, Soares HP, Gaspar HA et al (2004) Ratio between positive lymph nodes and total dissected axillaries lymph nodes as an independent prognostic factor for disease-free survival in patients with breast cancer. Am J Clin Oncol 27:304–306

    Article  PubMed  Google Scholar 

  19. Berger AC, Watson JC, Ross EA, Hoffman JP (2004) The metastatic/examined lymph node ratio is an important prognostic factor after pancreaticoduodenectomy for pancreatic adenocarcinoma. Am Surg 70:235–240

    PubMed  Google Scholar 

  20. Haboubi NY, Clark P, Kaftan SM, Schofield PF (1992) The importance of combining xylene clearance and immunohistochemistry in the accurate staging of colorectal carcinoma. J R Soc Med 85:386–388

    PubMed  CAS  Google Scholar 

  21. Palma RT, Waisberg J, Bromberg SH, Simão AB, Godoy AC (2003) Micrometastasis in regional lymph nodes of extirpated colorectal carcinoma: immunohistochemical study using anti-cytokeratin antibodies AE1/AE3. Colorectal Dis 5:164–168

    Article  PubMed  CAS  Google Scholar 

  22. Fleshman J, Sargent DJ, Green E, The Clinical Outcomes of Surgical Therapy Study Group et al (2007) Laparoscopic colectomy for cancer is not inferior to open surgery based on 5-year data from the COST Study Group trial. Ann Surg 246:655–662

    Article  PubMed  Google Scholar 

  23. Jayne DG, Guillou PJ, Thorpe H, UK MRC CLASICC Trial Group et al (2007) Randomized trial of laparoscopic-assisted resection of colorectal carcinoma: 3-year results of the UK MRC CLASICC Trial Group. J Clin Oncol 25:3061–3068

    Article  PubMed  Google Scholar 

  24. Lacy AM, Delgado S, Castells A et al (2008) The long-term results of a randomized clinical trial of laparoscopy-assisted versus open surgery for colon cancer. Ann Surg 248:1–7

    Article  PubMed  Google Scholar 

  25. Nelson H, Petrelli N, Carlin A, National Cancer Institute Expert Panel et al (2001) Guidelines 2000 for colon and rectal cancer surgery. J Natl Cancer Inst 93:583–596

    Article  PubMed  CAS  Google Scholar 

  26. Bilimoria KY, Bentrem DJ, Stewart AK et al (2008) Lymph node evaluation as a colon cancer quality measure: a national hospital report card. J Natl Cancer Inst 100:1310–1317

    Article  PubMed  Google Scholar 

  27. Priolli DG, Cardinalli IA, Pereira JA, Alfredo CH, Margarido NF, Martinez CA (2009) Metastatic lymph node ratio as an independent prognostic variable in colorectal cancer: study of 113 patients. Tech Coloproctol 13:113–121

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery A, Tel-Aviv Medical Center, Sackler Faculty of Medicine, Tel-Aviv University, 6 Weizmann Street, 64239, Tel-Aviv, Israel

    R. Greenberg, R. Itah, R. Ghinea, R. Inbar & S. Avital

  2. Department of Oncology, Tel-Aviv Medical Center, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel

    E. Sacham-Shmueli

Authors
  1. R. Greenberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. Itah
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. Ghinea
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. E. Sacham-Shmueli
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. R. Inbar
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. S. Avital
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S. Avital.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Greenberg, R., Itah, R., Ghinea, R. et al. Metastatic lymph node ratio (LNR) as a prognostic variable in colorectal cancer patients undergoing laparoscopic resection. Tech Coloproctol 15, 273–279 (2011). https://doi.org/10.1007/s10151-011-0701-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10151-011-0701-9

Keywords

Search

Navigation